Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Sweet’s Syndrome Associated with Recurrent Fever in a Patient with Trisomy 8 Myelodysplastic Syndrome

Abstract

In the case of a 69-year-old man suffering from recurrent high fever, laboratory data demonstrated elevated inflammatory findings such as neutrophilic leukocytosis and an increase in serum level of C-reactive protein. A nonsteroidal antiinflammatory drug or a low dose of prednisolone proved to be temporarily effective.A bone marrow specimen showed myelodysplastic syndrome (MDS) of the refractory anemia (RA) type with trisomy 8. Seven months after onset, painful erythematous eruptions were found on both legs. Biopsy of a skin lesion demonstrated neutrophic infiltration into the dermis. As a result, Sweet’s syndrome (SS) was diagnosed on the basis of clinical and histopathological findings. Administration of prednisolone (30 mg/d) was started and resulted in prompt defervescence and resolution of the lesions within 1 week.We also investigated serum levels of 3 cytokines: interleukin 1β (IL-1β), IL-6, and granulocyte colony-stimulating factor (G-CSF). Levels of IL-6 and G-CSF were elevated during the active phase, but the level of IL-1β did not increase. Because cases of MDS with trisomy 8 and SS or Behçet disease have been reported recently, our findings suggested that cytokine production, which enhances neutrophil function, is elevated in some MDS patients with trisomy 8; that is, not only cytokines but also trisomy 8 may be related to the pathogenesis of SS in MDS. It is thus advisable to watch for development of SS during follow-up of MDS patients with recurrent fever or trisomy 8.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Sweet RD. An acute febrile neutrophilic dermatosis.Br J Dermatol. 1964;76:349–356.

  2. 2.

    Cohen PR, Kurzrock R. Sweet’s syndrome: a neutrophilic dermatosis classically associated with acute onset and fever.Clin Dermatol. 2000;18:265–282.

  3. 3.

    Fett DL, Gibson LE, Daniel Su WP. Sweet’s syndrome: systemic signs and symptoms and associated disorders.Mayo Clin Proc. 1995;70:234–270.

  4. 4.

    Cohen PR, Talpaz N, Kurzrock R. Malignancy-associated Sweet’s syndrome: review of world literature.J Clin Oncol. 1988;6:1887–1897.

  5. 5.

    Cohen PR, Kurzrock R. Sweet’s syndrome and cancer.Clin Dermatol. 1993;11:149–157.

  6. 6.

    van Kamp H, van de Berg E, Timens W, Kraaijenbrink RA, Halie MR. Sweet’s syndrome in myeloid malignancy.Br J Haematol. 1993;86:415–417.

  7. 7.

    Sharma PK, Schwartz RA, Janniger CK, et al. Sweet’s syndrome with acute leukemia.Cutis. 1991;47:249–252.

  8. 8.

    Su WPD, Liu HNH. Diagnostic criteria for Sweet’s syndrome.Cutis. 1986;37:167–174.

  9. 9.

    Giasuddin AS, El-Orfi AH, Ziu MM, El-Barnawi NY. Sweet’s syndrome: is the pathogenesis mediated by helper T cell type 1 cytokines?J Am Acad Dermatol. 1998;39:940–943.

  10. 10.

    Going JJ. Is the pathogenesis of Sweet’s syndrome mediated by interleukin-I?Br J Dermatol. 1987;116:282–283.

  11. 11.

    Reuss-Borst MA, Pawelec G, Saal JG, Horny HP, Muller CA, Waller HD. Sweet’s syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the disease.Br J Haematol. 1993;84:356–358.

  12. 12.

    Loraas A, Waage A, Lamvik J. Cytokine response pattern in Sweet’s syndrome associated with myelodysplasia.Br J Haematol. 1994;87:669–671.

  13. 13.

    Billström R, Heim S, Kristoffersson U, Mandahl N, Mitelman F. Structural chromosomal abnormalities of 3q in myelodysplastic syndrome/acute myeloid leukemia with Sweet’s syndrome.Eur J Haematol. 1990;45:150–152.

  14. 14.

    Soppi E, Nousiainen T, Seppa A, Lahtinen R. Acute febrile neutrophilic dermatosis (Sweet’s syndrome) in association with myelodysplastic syndrome: a report three cases and a review of literature.Br J Haematol. 1989;73:43–47.

  15. 15.

    Nifosí G, Sbolli G, Ferrari B, et al. Sweet’s syndrome associated with monosomy 7 myelodysplastic syndrome.Eur J Intern Med. 2001;12:380–383.

  16. 16.

    Ohga S, Nomura A, Takada H, Terao H, Harada N, Hara T. Expansion of trisomy 8 and Sweet syndrome in a prolonged course of aplastic anemia.J Pediatr Hematol Oncol. 2002;24:64–68.

  17. 17.

    Kimura S, Kuroda J, Akaogi T, Hayashi H, Kobayashi Y, Kondo M. Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis-Behçet’s syndrome.Leuk Lymphoma. 2001;42:115–121.

  18. 18.

    Ohno E, Ohtsuka E, Watanabe K, et al. Behçet’s disease associated with myelodysplastic syndromes.Cancer. 1997;79:262–268.

Download references

Author information

Correspondence to Hideki Hattori or Shiro Hoshida or Shotaro Yoneda.

About this article

Cite this article

Hattori, H., Hoshida, S. & Yoneda, S. Sweet’s Syndrome Associated with Recurrent Fever in a Patient with Trisomy 8 Myelodysplastic Syndrome. Int J Hematol 77, 383–386 (2003). https://doi.org/10.1007/BF02982648

Download citation

Key words

  • Behçet disease
  • Myelodysplastic syndrome
  • Recurrent fever
  • Sweet’s syndrome
  • Trisomy 8